SWIFT is the CTC’s first cluster randomised registry-based controlled trial. SWIFT aims to determine the clinical effectiveness and cost-effectiveness of 3-monthly symptom monitoring using the Integrated Palliative Outcome Scale – Renal (IPOS-Renal) survey, with feedback to clinicians, compared with standard care (i.e. no routine symptom monitoring) in improving outcomes at 12 months for adults on haemodialysis.
NHMRC Project Grant
Adults aged 18 years and older with kidney failure managed with chronic haemodialysis at an Australian or New Zealand haemodialysis facility registered in ANZDATA.